Skip to main content
Clinical Trials/NCT01626599
NCT01626599CompletedNot Applicable

Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data

Cyberonics, Inc.6 sites in 1 country147 target enrollmentStarted: June 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
147
Locations
6
Primary Endpoint
Assess product useability

Study Overview

Brief Summary

This study is designed to collect data to support development of a novel product designed to sense changes in heart rate or movement during periods of sleep in people with epilepsy. When a potential seizure is detected, the system sends out an audio-visual notification.

Detailed Description

This is a prospective, interventional, un-blinded, non-significant risk, multi-site study.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
5 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Subjects must meet all of the following inclusion criteria:
  • •Five (5) years of age or older
  • •Caregiver capable of understanding and willing to comply with instructions provided in English for proper use of the study device as well as scheduled study visits.
  • •Guardian/Parent for subjects less than 18 years or with cognitive limitation that would preclude consent must be willing and able to complete informed consent/and HIPAA authorization.
  • •A self-reported diagnosis of epilepsy.
  • •Currently taking at least one antiepileptic medication.
  • •Caregivers must meet the following inclusion criteria:
  • •Eighteen (18) years of age or older
  • •Capable of understanding and willing to comply with instructions provided in english for proper use of the study device as well as scheduled study visits
  • •Willing and able to complete informed consent and HIPAA authorization.

Exclusion Criteria

  • •Subjects are not eligible to be enrolled in the study if they meet any of the following exclusion criteria:
  • •Any visible skin disorder, condition, or abnormal skin pigmentation which, in the investigators opinion, would interfere with the ability to wear the patch.
  • •History of chronic dermatological, medical, or physical conditions that would, in the investigators opinion, preclude topical application of the test products and/or influence the outcome of the test.
  • •Known sensitivity or history of irritation to adhesive tape (Latex) and/or topically applied products
  • •An implanted defibrillator and/or pacemakers
  • •Severe psychiatric disease that in the investigator's judgment would prevent the patient's successful completion of the study.
  • •Pregnant and or nursing women (verified by a urine pregnancy test).
  • •Currently participating in another clinical study without sponsor approval.
  • •Caregiver that is unable to read instructions in the English language.
  • •Exclusion Criteria for Caregiver:
  • •Under 18 years of age
  • •Not capable of understanding and willing to comply with instructions provided in English for proper use of the study device as well as scheduled study visits

Arms & Interventions

Assess product useability

Other

All subjects participate in the same arm. This arm completes the primary objective of product usability.

Intervention: ProGuardian (Device)

Outcomes

Primary Outcomes

Assess product useability

Time Frame: Up to 7 nights/7 days

This study is designed to collect usability data from the intended use population of people with epilepsy and their caregivers to support development of a novel product designed to capture ECG signals and accelerometer data.

Secondary Outcomes

  • Collect ECG and accelerometer data; device wearability; and evaluate adverse events.(Up to 7 nights/7 days)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (6)

Loading locations...

Similar Trials